Anticoagulation

Robert F Storey ,

Read time: 18m
HFA 24: The ARIES HM3 Trial

Finn Gustafsson,

Watch time: 7m 19s

Dirk Sibbing , Michael J Blaha , Rajinder Chawla , et al

Read time: 18m 10s
ACC.24 Late-breaking Science Preview

Listen time: 28m 10s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 9s

Juan Carlos Diaz , Mauricio Duque , Jorge Marin , et al

Read time: 18m
Apixaban Reduces Stroke Risk in Subclinical Atrial Fibrillation compared to Aspirin at the cost of Increased bleeding

Radcliffe Cardiology, Mirjam Boros; Special Editor: Greg Guillory

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s

Minh That Ton , Tri Huynh Quang Ho , Viet Lan Nguyen , et al

Read time: 18m

Tri Huynh Quang Ho , Minh That Ton , Viet Lan Nguyen , et al

Read time: 18m

Darren Mylotte, Marie-Claude Morice, Roisin Colleran, et al

Watch time: 28m 31s (3 videos)

Sonika Malik , Anju Bhardwaj , Matthew Eisen , et al

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Andreas Goette , Hein Heidbuchel ,

Marco Valgimigli, Eliano Navarese, Pascal Vranckx, et al

Watch time: 1h 48m 18s (11 videos)

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s
The Parallax Podcast

Ankur Kalra,

Kerry Layne , Albert Ferro ,

Stuart J Head , Ad JJC Bogers , A Pieter Kappetein ,

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Julia Sikorska , James Uprichard ,

Georg Nickenig, Todd Villines, Christopher P Cannon, et al

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Yugo Yamashita,

Marco Valgimigli, Eliano Navarese, Pascal Vranckx, et al

Watch time: 1h 48m 18s (11 videos)

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Media

HFA 24: The ARIES HM3 Trial

Finn Gustafsson,

Watch time: 7m 19s

A John Camm, Marco Alings, Raffaele De Caterina, et al

Jeff Dahlen, Robert F Storey, Guillaume Taylor, et al

A John Camm, Paulus Kirchhof, Raffaele De Caterina, et al

ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 9s
Cardiovascular Outcomes For People Using Anticoagulation Strategies At ESC 2017 discuss with Professor Eugene Braunwald

Eugene Braunwald, Afzal Sohaib,

Watch time: 8m 50s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s

Ignacio Cruz, Jens Erik Nielsen Kudsk, Prof Henning Ebelt, et al

Watch time: 2h 5m 51s

David Hildick-Smith, Tim Betts, A John Camm, et al

Watch time: 1h 32m 45s
View from the Thoraxcenter – What's hot at ACC 2020

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 17m 52s

Articles

Volume Management in Critically Ill Patients

Frédéric Michard

,

Citation:

European Cardiology 2008;4(1):99–100

DOI:

https://doi.org/10.15420/ecr.2008.4.1.99
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5185
  • Downloads: Downloads 16

Anti-platelet Therapy for Congestive Heart Failure

Victor L Serebruany

,

Citation:

US Cardiology 2004;1(1):1–6

Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 812
  • Downloads: Downloads 5

Atrial Fibrillation—Recent Key Trials on Anticoagulation

Stefan H Hohnloser

,

Citation:

US Cardiology 2007;4(1):18–9

DOI:

https://doi.org/10.15420/usc.2007.4.1.18
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1320
  • Downloads: Downloads 4

Individualised Antiplatelet Therapy

Jean-Philippe Collet

,

Jochem Wouter van Werkum

,

Citation:

European Cardiology 2010;6(1):41–9

DOI:

https://doi.org/10.15420/ecr.2010.6.1.41
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 292
  • Downloads: Downloads 6
  • Citations: 2